Evacarb Dosage & Drug Information

Indications/Uses

Treatment of postpartum hemorrhage due to uterine atony which has not responded to conventional methods of management.

Dosage/Direction for Use

Refractory postpartum uterine bleeding Initially 250 mcg inj given in deep IM. Max: 2 mg (8 doses).

Contraindications

Hypersensitivity. Acute pelvic inflammatory disease; active cardiac, pulmonary, renal or hepatic disease.

Special Precautions

History of asthma, hypotension or HTN, CV, renal or hepatic disease, anemia, jaundice, diabetes or epilepsy; compromised (scarred) uteri; incomplete abortion; chorioamnionitis. Risk of transient pyrexia; increased BP in the postpartum hemorrhage. Carefully examine cervix post-abortion. Pregnancy. Childn.

Adverse Reactions

Vomiting, diarrhea, hyperpyrexia & flushing.

View ADR Reporting Link

Drug Interactions

May augment the activity of other oxytocic agents. Enhanced action of oxytocin.

MIMS Class

Drugs Acting on the Uterus

ATC Classification

G02AD04 - carboprost ; Belongs to the class of prostaglandins. Used to induce abortion or augment labour and to minimize blood loss from the placental site.

Regulatory Classification

Rx

Presentation/Packing

Form

Evacarb soln for inj 125 mcg/0.5 mL

Packing/Price

10 × 1's;5 × 1's

Form

Evacarb soln for inj 250 mcg/mL

Packing/Price

10 × 1's;5 × 1's

Evacarb

carboprost

Manufacturer:

MedEthix

Distributor:

MedEthix